News & Events
- All
- Company
- Events
- Press Releases
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development [Cambridge, UK, December 4, 2024] - Abselion, an innovator in...
Abselion is delighted to announce the appointment of Dr Anne Jones to the board of the company as non-executive director. Anne brings over 25 years of global commercial experience in the Life...
Collaborative Project to Develop Next-Generation Cell Platform for Viral Vector Production Receives £1.1 Million Grant from Innovate UK & NRC Cambridge (UK) & Montreal (Canada), August...
Abselion is celebrating a significant achievement winning the coveted Bioprocessing Industry Association 2023 award for Next-Gen Analytics at the annual industry gathering. This recognition comes in...
The last few years have been nothing short of amazing – together, we have achieved remarkable milestones that we can all be incredibly proud of. From winning countless awards to securing...
When HexagonFab was founded in 2018 we did not set out to change the world. What we set out to do instead is to create tools that empower scientists to do research faster and easier than ever...
HexagonFab secures £1.9m (USD 2.6m) seed funding to launch the Bolt, an analytical lab instrument to speed discovery and production of next-generation biopharmaceuticals The Bolt provides...
